Bausch & Lomb (BLCO) Research & Development (2021 - 2026)
Bausch & Lomb (BLCO) reported Research & Development of $101.0 million for Q1 2026, up 17.44% on a YoY basis from $86.0 million in Q1 2025, and up 7.45% quarter-over-quarter from $94.0 million in Q4 2025.
Bausch & Lomb (BLCO) Research & Development (2021 - 2026) Analysis & Trends
Bausch & Lomb has reported Research & Development for 6 years, with the latest figure at $101.0 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 17.44% year-over-year to $101.0 million; the trailing twelve-month figure through Mar 2026 stood at $386.0 million (up 11.24% YoY), and the FY2025 full-year result was $371.0 million, up 8.16% from the prior year.
- Research & Development for Q1 2026 stood at $101.0 million, up from $94.0 million in the prior quarter.
- The five-year high for Research & Development was $101.0 million in Q1 2026, with the low at $75.0 million in Q2 2022.
- Historically, Research & Development has averaged $85.1 million across 5 years, with a median of $84.0 million in 2024.
- Annual changes were most pronounced in 2022 — Research & Development grew 22.22% — and 2024, when it declined 1.18%.
- Bausch & Lomb's Research & Development stood at $78.0 million in 2022, then climbed by 2.56% to $80.0 million in 2023, then advanced by 16.25% to $93.0 million in 2024, then advanced by 1.08% to $94.0 million in 2025, then grew by 7.45% to $101.0 million in 2026.
- The last three Research & Development figures came in at $101.0 million (Q1 2026), $94.0 million (Q4 2025), and $95.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 94.27 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 15.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 189.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 98.66 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 139.00 Mn |
| 10 | Bausch & Lomb | 5.32 Bn | 5.12 Bn | 973.00 Mn | 101.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.00 Mn |
| Dec 31, 2025 | 94.00 Mn |
| Sep 30, 2025 | 95.00 Mn |
| Jun 30, 2025 | 96.00 Mn |
| Mar 31, 2025 | 86.00 Mn |
| Dec 31, 2024 | 93.00 Mn |
| Sep 30, 2024 | 84.00 Mn |
| Jun 30, 2024 | 84.00 Mn |
| Mar 31, 2024 | 82.00 Mn |
| Dec 31, 2023 | 80.00 Mn |
| Sep 30, 2023 | 82.00 Mn |
| Jun 30, 2023 | 85.00 Mn |
| Mar 31, 2023 | 77.00 Mn |
| Dec 31, 2022 | 78.00 Mn |
| Sep 30, 2022 | 77.00 Mn |
| Jun 30, 2022 | 75.00 Mn |
| Mar 31, 2022 | 77.00 Mn |
| Dec 31, 2021 | 70.00 Mn |
| Sep 30, 2021 | 63.00 Mn |
| Jun 30, 2021 | 71.00 Mn |